India testing multi-purpose vaccine against the coronavirus | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Food
    • Habitat
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
The Business Standard

Tuesday
December 05, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Food
    • Habitat
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
TUESDAY, DECEMBER 05, 2023
India testing multi-purpose vaccine against the coronavirus

Coronavirus chronicle

TBS Report
17 April, 2020, 08:50 pm
Last modified: 17 April, 2020, 08:53 pm

Related News

  • Pfizer says 3 Covid shots protect children under 5
  • Covax calls for urgent action to close vaccine equity gap
  • US to share Covid vaccine technology, Biden tells global summit
  • Britain approves Valneva's easy-to-store Covid shot
  • More funds incoming from dev partners for vaccine purchase

India testing multi-purpose vaccine against the coronavirus

The World Health Organisation has said a specific vaccine for the novel coronavirus that has triggered the ongoing Covid-19 pandemic could take at least 12 months or longer

TBS Report
17 April, 2020, 08:50 pm
Last modified: 17 April, 2020, 08:53 pm
India testing multi-purpose vaccine against the coronavirus

Scientists in India are testing a multi-purpose vaccine that has proved effective against leprosy and boosts immunity in hosts to see if it can help tackle the coronavirus.

The chief of India's largest public-funded research institution disclosed the information on Friday, reports the NDTV.

"With the approval of the DCGI (Drug Controller General of India), we have begun tests on the MW vaccine that has been successfully used against leprosy," said Dr Shekhar Mande, director general of the Council of Scientific and Industrial Research (CSIR).

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

"Making a vaccine is a lengthy process. The research is going on. We are working on a vaccine that improves the immunity in hosts. We are awaiting two more approvals. Once we have those, we will start trials. We will know the results within the next six weeks," Dr Mande said.

The World Health Organisation has said a specific vaccine for the novel coronavirus that has triggered the ongoing Covid-19 pandemic could take at least 12 months or longer.

Several countries including the US and China are working on vaccines to counter the fast-spreading respiratory virus that has affected over 21 lakh people across the world and killed nearly 1.5 lakh.

In India, over 13,000 people have been infected and 437 have died.

Mande said India is working on genome sequencing of the virus that will help trace its origin and spread. It can also help understand if the virus is mutating and developing resistance to drugs being used against it.

"The National Institute of Virology in Pune has done 25 sequencing. We have done 30 sequencing in two of our labs. We do some 500 to 1,000 in the coming two weeks," he said.

"There are around six to seven strains (of coronavirus) in the world. It is too early to say how many strains we have in India. We will find that out as we perform more sequencing," Mande added.

Coronavirus Vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Illustration: TBS
    Finance minister's wealth drops after giving money away to wife, daughter, grandchildren
  • Photo: Collected
    Bangladesh to ask WB for $250m more in budget support
  • This file photo from December 2019 shows a rider driving his motorcycle through cold wind and fog. A scene not yet visible this year. Photo: Mumit M
    Why is 'winter not coming' yet

MOST VIEWED

  • LPG cylinders. Photo: Courtesy
    12kg LPG cylinder price up Tk23
  • For the first time, Bangladesh seeks foreign loans to support Rohingyas
    For the first time, Bangladesh seeks foreign loans to support Rohingyas
  • Photo: Collected
    Indonesia volcano erupts, spews ash 3 km into sky
  • External trade through Islamic banks in decline
    External trade through Islamic banks in decline
  • Halal products export receives boost with new policy, but more is required
    Halal products export receives boost with new policy, but more is required
  • Exports up 27% in Nov as peak festival sales begin in West
    Exports up 27% in Nov as peak festival sales begin in West

Related News

  • Pfizer says 3 Covid shots protect children under 5
  • Covax calls for urgent action to close vaccine equity gap
  • US to share Covid vaccine technology, Biden tells global summit
  • Britain approves Valneva's easy-to-store Covid shot
  • More funds incoming from dev partners for vaccine purchase

Features

Ghulam Ali

Ghulam Ali: Voice that makes ghazals bloom

1h | Features
Exploring door designs: Redefining spaces and experiences

Exploring door designs: Redefining spaces and experiences

3h | Habitat
A brain drain query: Why do they leave?

A brain drain query: Why do they leave?

8h | Panorama
The school has been flooding since June 2007 and the water level is rising every year. PHOTO: COURTESY

Will Dubai pay heed to the suffering of Sultan Al Nahyan School students in Bangladesh?

8h | Panorama

More Videos from TBS

Labour Bill to be reintroduced in 12th Parliament

Labour Bill to be reintroduced in 12th Parliament

2h | TBS Economy
November export earnings up 27 percent over previous month: EPB

November export earnings up 27 percent over previous month: EPB

4h | TBS Economy
Amitabh Bachchan's assets worth Rs 3,700 crore divided

Amitabh Bachchan's assets worth Rs 3,700 crore divided

3h | TBS Entertainment
External trade through Islamic banks in decline

External trade through Islamic banks in decline

5h | TBS Economy
EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]